Avalyn Pharma

About Avalyn Pharma

Avalyn Pharma is a clinical-stage biotechnology company focused on developing inhaled therapies to treat rare respiratory diseases. Their work centers on delivering targeted treatments directly to the lungs, with a focus on conditions such as pulmonary fibrosis. The company operates in the biotech and healthcare research space, advancing novel inhalation approaches from discovery through early clinical development. Based in the United States, Avalyn Pharma aims to improve outcomes for patients with hard-to-treat rare lung diseases through scientific innovation and translational science.